Cantor Fitzgerald Downgrades Humana to Neutral, Lowers Price Target to $391
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has downgraded Humana (NYSE:HUM) from Overweight to Neutral and reduced the price target from $597 to $391.

January 26, 2024 | 7:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Humana downgraded by Cantor Fitzgerald from Overweight to Neutral with a significant price target cut from $597 to $391.
Downgrades by analysts can lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The substantial reduction in the price target further emphasizes a less optimistic outlook on the company's valuation, which could lead to selling pressure.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100